Bahçeci Health Group, one of the major providers of fertility services in Türkiye, entered into transaction agreements for the strategic acquisition of its shares by FutureLife, a major pan-European provider of fertility, IVF and genetics services and backed by CVC Capital Partners and Hartenberg Holding. The completion of the transaction is subject to fulfilment of conditions precedent including the Turkish Competition Authority’s approval.
Paksoy is pleased to announce that a team led by partner Elvan Aziz, along with senior associates Pınar Babaoğlu and Deniz Benli Kandiyoti, is acting as Turkish counsel to Bahçeci Group in this transaction.
Share
Related persons
You can contact us for detailed information.



Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
18 February 2026
Once again, we are recognised among the top-tier in the Chambers Global Guide 2026
We are appreciative of the continued top-tier recognition of our firm and lawyers by the Chambers Global Guide 2026.
16 February 2026
Paksoy advised H.I.G. Capital on its acquisition of Atlas Dunnage
Paksoy advised H.I.G. Capital on its acquisition of Atlas Dunnage.
12 February 2026
Paksoy advised Tiryaki Agro on its acquisition of Savola Foods Turkey
Paksoy advised Tiryaki Agro on its acquisition of Savola Foods Turkey.
19 January 2026
Paksoy advises Amphenol on its acquisition of CommScope’s CCS business
Paksoy advises Amphenol Corporation on its acquisition of CommScope’s Connectivity and Cable Solutions (CCS) business.
14 January 2026
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ.
13 January 2026
Paksoy advised IFC on its investment in Getmobil
Paksoy advised IFC on its investment in Getmobil.